7. Antibiotics Flashcards

1
Q

How much of antibiotic use is inappropriate?

A

50% of antbiotic therapy - baring in mind 25% of inpatients are on antibiotics and 2/3 will be put on antibiotics at some stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antibiotic misuse and relationship consequences

A

MRSA, VRE
C. diff
Resistant Enterobacteriaceae esp E. coli and K. pneumonieae
- Extended spectrum Beta-lactamase (ESBL) producers
Carbapenemase producing enterobacteriaceae (CPE)
Klebsiella producing carbapenemases (KPC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Does antibiotic use affect patients on an individual basis

A

places individual patients at risk of resistant infection - including UTIs and RTIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

key agents which bacteria can be resistant to?

A

co-amoxiclav, ciprofloxacin, piperacillin-tazobactam, gentamicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which bacteria are antibiotic resistances most common in?

A

Gram negatives like E. coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Principles of safe and rational prescribing of antibiotics - the initial prescribing decision

A

Microbial aetiology - where the infection is, where they caught it (hosp vs community) - focus and exposure

Antimicrobial resistance - epidemiology and exposure

Patient factors - predisposition and severity

Antibiotic knowledge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rational use of antibiotics demands consideration of:

A

The aetiological agent (AMR potential)

The patient

The drug (mechanism of action-> spectrum of activity
mechanisms of resistance
key pharmacology

Monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is antimicrobial stewardship?

A

Using antibiotics wisely and responsibly taking into account the long-term effects of antimicrobial selection, dosage, and duration of treatment on resistance developing

Key feature of health policy in the NHS
enforced by the 2008 health and social care act

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aims of antimicrobial stewardship

A

enhance health outcomes
reduce antibiotic resistance
decrease unnecessary costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is TARGET?

A

An Antibiotics toolkit that helps to influence prescribers’ and patient’s personal attitudes, social norms and perceived barriers to optimal antibiotic prescribing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Are inpatients or outpatients more at risk from infection?

A

Inpatients, need to be especially on the lookout for prompt recognition and treatment of sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sepsis signs

A
Systolic BP <90mmHg
Lactate >2mmol/l
Heart rate > 130 per minute
Resp rate>25 per mintue
O2 sats <91%
Responds only to voice or pain/unresponsive
purpuric rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sepsis treatment

A

Give IV antibiotics in the first hour according to trust policy (TAKE ALLERGY HX FIRST)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Start smart part of start smart then focus

A

Do not start antibiotics in absence of clinical evidence of bacterial infection
Take drug allergy hx, give w/i 1 hour of infection, local antimicrobial guidelines, document clinical indication, dose and route on drug chart and in notes, include duration and review/stop date, obtain cultures before therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Focus part of start smart then focus

A

Clinical review & decision after 48-72 hours
Clinical review, check micro and make clear plan, document the decision

  1. Stop
  2. Switch IV to oral
  3. Change antibiotic
  4. Continue
  5. OPAT (outpatient parenteral antibiotic therapy)

Document all decisions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drivers to stop antibiotics

A

Toxicity

Risk of AMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drivers to continue antibiotics

A

Personal responsibility
Reluctance to interfere
patient outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Most common outcome of focussing antibiotics?

A

95% of review and revise decisions are to continue Abx treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Things to keep in mind when you review?

A

Remember antibiotics are harmful?
Did they ever have an infection?
Are they better now?
Do the risks of continuing outweigh the benefits?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Key points about rational antibiotics antibiotic prescribing decisions

A

Two moments

  1. Initial prescription:
    - microbial aetiology
    - patient factors
    - antimicrobial resistance issues
    - knowledge
    - guidelines - choice of agent, duration of therapy
  2. Review and revise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Amoxicillin

A

An aminopenicillin

particularly strong against Gram negative bacteria

used to treat S. pyogenes infections (sore throat, skin infections), pneumococcal infections(RTIs), coliform/UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Mechanism of action of amoxicillin

A

Inhibition of bacterial cell wall synthesis

23
Q

Standard dose of amoxicillin, side effects and drug interactions

A

250-1000mg 8 hourly

allergy, damage to commensal microflora

Interactions: can increase levels of other protein bound drugs

24
Q

Amoxicillin

A
good oral bioavailability
Protein binding 20%
Metabolism not significant
Half-life 1 hour
Excretion 1 hour
25
Beta-lactam antibiotics
Penicillins - penicillin G, penicillin V, Amoxicillin, coamoxiclav, flucloxacillin, piperacillin Cephalosporins e.g. cephalexin and cefuroxime carbapenams e.g. meropenem
26
the easy oral pencillin
Amoxicillin
27
Amox protected against beta-lactamases
co-amoxiclav
28
The penicillin for Staph aureus
flucloxacillin
29
Penicillin for pseudomonas
piperacillin
30
Beta lactam allergy
``` Penicillin allergy - a class effect - immediate/ accelerate - type 1 (0.02% of courses) Delayed - mixed mechanism (2-3% of courses) ```
31
Type 1 penicillin allergy
Immediate - 0-72hrs after exposure IgE mediated, mast cell mediated Urticaria, wheeze, life threatening 0.02% of courses
32
Delayed penicillin allergy
2-3% of courses >72 after exposure Will worsen with repeated exposure does not become immediate type
33
Cephalosporin allergy
Very complicated - lots of potential haptens involved Not a class effect Penicillin X-reactivity more with 1st and 2nd generations Risk ~8% if previous penicillin allergy Less with 3rd generation
34
History of beta-lactam allergy
When was it? What happened - time course and severity? What was the drug? Might they have had glandular fever? Have they had a different beta lactam since? good history of anaphylaxis - avoid all beta lactams Weak history or of delayed reaction - consider rechallenge
35
Clarithromycin
Macrolide w similar spectrum of action to amoxicillin Used for pts with penicillin allergy to treat S. pyogenes infections (sore throat and skin infections) pneumococcal infections (respiratory tract) coliform infections (UTIs) Also against cell-wall deficient bacteria e.g. chlamydia which causes penumonia and GU infections
36
Clarithromycin pharmacokinetics
``` Good oral bioavailability high protein binding hepatic metabolism 1-6 hours half Excretion as metabolites in bile ```
37
Clarithromycin mechanism of action
inhibition of protein synthesis bacterial ribosome (50s subunits)
38
Adverse effects and interactions of clarithromycin
Nausea and diarrhoea, may alter cardiac conduction - arrhythmias interactions - inhibits enzymes (cytochrome p450 enzymes) involved in the metabolism of other drugs
39
Standard dose of clarythromycin
500mg 12 hourly
40
Vancomycin
a glycopeptide active only against Gram-positive bacteria and is active against resistance strains including MRSA
41
Vancomycin pharmacokinetics
``` V low oral bioavailability 50% protein binding No metabolism 4-8 hours half life Excreted as urine ```
42
Mechanism of action of vancomycin
inhibits bacterial cell wall (peptidoglycans) formation by a different target to beta lactams
43
Standard dose
500-1500mg 12 hourly Narrow therapeutic window (levels needed to kill the bacteria v close to level toxic to pt) Dose by drugs level in blood
44
Adverse effects and interaction
Nephrotoxic and ototoxic | Interacts w other ototoxic and nephrotoxic drugs
45
Doxycycline
A tetracycline w good activity against Gram positive e.g. Streps and Staphs against some Gram negs e.g. haemophilus Active against cell-wall deficient bacteria e.g. chlamydia which cause pneumonia and genitourinary infections Poor against Enterobacteriaceae, anaerobes Used for skin, resp tract, genital tract infections Loe C diff risk
46
Mechanism of action of doxycycline
Inhibition of protein synthesis in the bacterial ribosome (30s subunit)
47
Adverse effects and interactions of doxycycline
Dyspepsia, photosensitivity, avoid in pregnancy/children (teeth) Interactions: competes for protein binding - warfarin, digoxin etc
48
Doxycycline
``` good oral bioavaialbity Moderate protein binding No metabolism Half-life 6-12 hours Excreted in urine and bile ```
49
Standard dose of doxycycline
100-200mg daily
50
Nitrofurantoin
Only nitrofuran Wide spectrum - esp E. coli and other enterobactericeae, enterococci, staphs, some streps Use for lower UTIs only too little tissue penetration elsewhere
51
Mechanism of action of nitrofurantoin
complex. Damages bacterial DNA | High resistance threshold
52
Adverse effects of nitrofurantoin
V well tolerated Safe in early pregnancy - avoid late Avoid in renal impairment - peripheral neuropathy, doesn't uterine if eGFR low no major interactions
53
Standard dose of nitrofurantoin
50mg qds